Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Chubb
Chinese Patent Office
Healthtrust
Dow
Moodys
US Army
Farmers Insurance
US Department of Justice
Teva

Generated: January 24, 2018

DrugPatentWatch Database Preview

ESCITALOPRAM OXALATE Drug Profile

« Back to Dashboard

When do Escitalopram Oxalate patents expire, and when can generic versions of Escitalopram Oxalate launch?

Escitalopram Oxalate is a drug marketed by Mylan Pharms Inc, Amneal Pharms, Antrim Pharms Llc, Aurobindo Pharma Ltd, Hetero Labs Ltd Iii, Macleods Pharms Ltd, Silarx Pharms Inc, Taro, Accord Hlthcare, Apotex Inc, Hikma Pharms, Invagen Pharms, Jubilant Generics, Lupin Ltd, Prinston Inc, Sti Pharma Llc, Teva Pharms Usa, Torrent Pharms Ltd, and Zydus Pharms Usa Inc. and is included in twenty-three NDAs.

The generic ingredient in ESCITALOPRAM OXALATE is escitalopram oxalate. There are twenty-six drug master file entries for this compound. Sixty-three suppliers are listed for this compound. There are six tentative approvals for this compound. Additional details are available on the escitalopram oxalate profile page.
Summary for ESCITALOPRAM OXALATE
Drug patent expirations by year for ESCITALOPRAM OXALATE
Pharmacology for ESCITALOPRAM OXALATE

US Patents and Regulatory Information for ESCITALOPRAM OXALATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Prinston Inc ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 078032-001 Aug 28, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lupin Ltd ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 078169-001 Sep 11, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms Usa ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 076765-003 Mar 14, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sti Pharma Llc ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 077512-002 Sep 12, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Torrent Pharms Ltd ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 090939-001 Sep 11, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Zydus Pharms Usa Inc ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 077734-003 Sep 11, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Invagen Pharms ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 078604-003 Sep 11, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lupin Ltd ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 078169-002 Sep 11, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Jubilant Generics ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 202280-001 Sep 12, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc ESCITALOPRAM OXALATE escitalopram oxalate CAPSULE;ORAL 077660-001 Jul 31, 2007 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Johnson and Johnson
UBS
Cantor Fitzgerald
Healthtrust
Deloitte
Daiichi Sankyo
Accenture
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot